Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „presented“
Suchtreffer
Begriffe & Kennungen
Iressa · 4.8 · The safety profile presented in Table 1 is based on the gefitinib clinical development programme and postmarke
Eintrag öffnenIressa · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Table 1
Eintrag öffnenJevtana · 4.8 · The incidences from the pooled analysis of these 3 trials are presented below and in the tabulated list. The m
Eintrag öffnenJivi · 4.8 · The table presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level
Eintrag öffnenKadcyla · 4.8 · The ADRs in 2 611 patients treated with trastuzumab emtansine are presented in Table 3. The ADRs are listed be
Eintrag öffnenKanjinti · 4.8 · Details of risk minimisation measures that are consistent with the EU Risk Management Plan are presented in (s
Eintrag öffnenKanjinti · 4.8 · Presented in Table 1 are adverse reactions that have been reported in association with the use of intravenous
Eintrag öffnenKiovig · 4.8 · The tables presented below are according to the MedDRA system organ classification (SOC and Preferred Term Lev
Eintrag öffnenKiovig · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenKostaive · 4.8 · The safety profile presented below is based on data from 2 clinical studies: • Study ARCT-154-01, conducted to
Eintrag öffnenKuvan · 4.8 · 8 Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenKuvan · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenKyprolis · 4.8 · Adverse reactions are presented below by system organ class and frequency category (see table 6). Frequency ca
Eintrag öffnenLantus · 4.8 · 7 Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenLeflunomide medac · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenLeflunomide ratiopharm · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenLenvima · 4.8 · 15 Within each frequency category, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnen